Disclosure Plus

Knowmerce Corp. Signs Trust Agreement to Acquire 1 Billion Won Worth of Treasury Stock

Park Sun-Yeop
2026-07-15 16:22:04
[Edaily Reporter Park Sun-Yeop ] #Knowmerce Corp. announced on the 15th that it has decided to enter into a trust agreement with SamsungSecurities for the acquisition of 1 billion won worth of its own shares.
The contract period is six months, from today through January 15 of next year. The planned acquisition consists of 98,328 common shares, with a base price of 10,170 won per share.
Knowmerce Corp. currently holds 54,618 shares of treasury stock acquired within the scope of distributable earnings. This represents 0.49% of the total issued shares.
The company explained that the purpose of this trust agreement is to stabilize the stock price and enhance shareholder value. Both the contracting institution and the entrusted investment broker are SamsungSecurities.

Economy

Corporation

IT·Science

Economy

"AI Broadcasts on Its Own"... A Creator Startup Founded by a Former TikTok Employee [VC Cradle]

A virtual creator that doesn’t require a human actor has emerged. There is no pre-written script, nor is there an operator manipulating it in real time. Artificial intelligence (AI) hosts the broadcas…
2026-08-08 11:01:04

Corporation

Mezzion Pharma Co., Ltd. Simultaneously Improves Cysts and Kidney Function in ADPKD… “Moving Directly to Phase 2b Clinical Trials in Korea and the U.S.”

“When you examine the kidneys of mice with polycystic kidney disease, you can see large cysts. However, after administering Udenafil, a reduction in the size of these cysts was visible even to the nak…
2026-08-08 08:16:01

IT·Science

SK BIOPHARMACEUTICALS Soars on Cenobamate Growth… The Era of 45% Generic Drug Prices Begins [Weekly Bio Roundup]

(Graphic: Generative AI) During the first week of August (August 3–7), SK BIOPHARMACEUTICALS posted its best-ever quarterly earnings, driven by the growth of its new epilepsy drug “cenobamate.” Ad…
2026-08-08 08:31:03